Sign in
Taking peopleNo phase

Prevalence and Clinical Implications of HPV Infection in Male IBD Patients

Key facts

Who runs it
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Where
Spain1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
384 people, planned
Started
12 Feb 2023
Planned end
1 Jun 2026
Type of study
Observational
Treatments tested
  • Anal pap smear and oral swab for cytology and HPV testing
Record updated
12 September 2025

Who can take part

Age
18 years to 79 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Diagnosed Crohn's disease or ulcerative colitis (at least 3 months before enrollment)
  • Male
  • Age from 18 to 79 years

Who cannot take part

  • Prior full proctectomy
  • Unclassified Inflammatory Bowel Disease
  • Diarrhea (> 3 bowel movements/day) with rectal bleeding at enrollment
  • Inability to collect the biological samples
  • Inability to complete the questionnaire
  • Refusal to sign the informed consent

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 79 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.

The group in the trial

  • Male IBD patients

    Male patients with a confirmed diagnosis of Inflammatory Bowel Disease (Crohn´s disease or Ulcerative colitis).

    Treatment: Anal pap smear and oral swab for cytology and HPV testing

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prevalence and Clinical Implications of Human Papillomavirus Infection in the Male Population With Inflammatory Bowel Disease
Criteria questions
Built from NCT05911750, who can take part
Record updated
12 September 2025